Incidence, Clinical Characteristics and Management of Inflammatory Bowel Disease in Spain: Large-Scale Epidemiological Study

Clicks: 118
ID: 276214
2021
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #239 of 253 articles by views in journal of clinical medicine

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 253 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Abstract
(1) Aims: To assess the incidence of inflammatory bowel disease (IBD) in Spain, to describe the main epidemiological and clinical characteristics at diagnosis and the evolution of the disease, and to explore the use of drug treatments. (2) Methods: Prospective, population-based nationwide registry. Adult patients diagnosed with IBD—Crohn’s disease (CD), ulcerative colitis (UC) or IBD unclassified (IBD-U)—during 2017 in Spain were included and were followed-up for 1 year. (3) Results: We identified 3611 incident cases of IBD diagnosed during 2017 in 108 hospitals covering over 22 million inhabitants. The overall incidence (cases/100,000 person-years) was 16 for IBD, 7.5 for CD, 8 for UC, and 0.5 for IBD-U; 53% of patients were male and median age was 43 years (interquartile range = 31–56 years). During a median 12-month follow-up, 34% of patients were treated with systemic steroids, 25% with immunomodulators, 15% with biologics and 5.6% underwent surgery. The percentage of patients under these treatments was significantly higher in CD than UC and IBD-U. Use of systemic steroids and biologics was significantly higher in hospitals with high resources. In total, 28% of patients were hospitalized (35% CD and 22% UC patients, p < 0.01). (4) Conclusion: The incidence of IBD in Spain is rather high and similar to that reported in Northern Europe. IBD patients require substantial therapeutic resources, which are greater in CD and in hospitals with high resources, and much higher than previously reported. One third of patients are hospitalized in the first year after diagnosis and a relevant proportion undergo surgery.
Reference Key
chaparro2021incidencejournal Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Chaparro, María;Garre, Ana;Ortiz, Andrea Núñez;Palomares, María Teresa Diz-Lois;Rodríguez, Cristina;Riestra, Sabino;Vela, Milagros;Benítez, José Manuel;Salgado, Estela Fernández;Rodríguez, Eugenia Sánchez;Hernández, Vicent;Ferreiro-Iglesias, Rocío;Díaz, Ángel Ponferrada;Barrio, Jesús;Huguet, José María;Sicilia, Beatriz;Martín-Arranz, María Dolores;Calvet, Xavier;Ginard, Daniel;Alonso-Abreu, Inmaculada;Fernández-Salazar, Luis;Trastoy, Pilar Varela;Rivero, Montserrat;Vera-Mendoza, Isabel;Vega, Pablo;Navarro, Pablo;Sierra, Mónica;Cabriada, José Luis;Aguas, Mariam;Vicente, Raquel;Navarro-Llavat, Mercè;Echarri, Ana;Gomollón, Fernando;Río, Elena Guerra del;Piñero, Concepción;Casanova, María José;Spicakova, Katerina;Zarate, Jone Ortiz de;Cortés, Emilio Torrella;Gutiérrez, Ana;Alonso-Galán, Horacio;Hernández-Martínez, Álvaro;Marrero, José Miguel;Poyatos, Rufo Lorente;Calafat, Margalida;Romero, Lidia Martí;Robledo, Pilar;Bosch, Orencio;Jiménez, Nuria;Comas, María Esteve;Duque, José María;Coronel, Ana María Fuentes;Sampedro, Manuela Josefa;Abizanda, Eva Sesé;Martínez, Belén Herreros;Pozzati, Liliana;Rosáenz, Hipólito Fernández;Suarez, Belén Crespo;Serrano, Pilar López;Lucendo, Alfredo J.;Vicente, Margarita Muñoz;Bermejo, Fernando;Palanca, José Joaquín Ramírez;Menacho, Margarita;Carmona, Amalia;Camargo, Raquel;Alsina, Sandra Torra;Maroto, Nuria;Puerta, Juan Nerín de la;Castro, Elena;Marín-Jiménez, Ignacio;Botella, Belén;Sapiña, Amparo;Cruz, Noelia;Forcelledo, José Luis F.;Bouhmidi, Abdel;Castaño-Milla, Carlos;Opio, Verónica;Nicolás, Isabel;Kutz, Marcos;Bechiarelli, Alfredo Abraldes;Gordillo, Jordi;Ber, Yolanda;Domínguez, Yolanda Torres;Durán, María Teresa Novella;Mondéjar, Silvia Rodríguez;Martínez-Cerezo, Francisco J.;Kolle, Lilyan;Sabat, Miriam;Ledezma, Cesar;Iyo, Eduardo;Roncero, Óscar;Irisarri, Rebeca;Lluis, Laia;Gómez, Isabel Blázquez;Zapata, Eva María;Alcalá, María José;Pascual, Cristina Martínez;Montealegre, María;Mata, Laura;Monrobel, Ana;Camba, Alejandro Hernández;Hernández, Luis;Tejada, María;Mir, Alberto;Galve, María Luisa;Soler, Marta;Hervías, Daniel;Gómez-Valero, José Antonio;Acosta, Manuel Barreiro-de;Rodríguez-Artalejo, Fernando;García-Esquinas, Esther;Gisbert, Javier P.;GETECCU, on behalf of the EpidemIBD study group of;
Journal journal of clinical medicine
Year 2021
DOI
DOI not found
URL
Keywords

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.